Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-30

Clinical Trial Update: Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating NUTRICAN to improve nutritional status in cancer patients is ongoing, including lung and cervical cancer. The current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NUTRICAN

Snippet

Sponsor: Kalbe International Pte. Ltd | Conditions: Malnutrition; Protein, Cancer, Lung | Phase 3 | Status: UNKNOWN